Cargando…

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection

Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and outcomes of disease. Increasing experience with analysis of HBV genomic data o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Downs, Louise O., McNaughton, Anna L., de Cesare, Mariateresa, Ansari, M. Azim, Martin, Jacqueline, Woodrow, Charles, Bowden, Rory, Collier, Jane, Barnes, Eleanor, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802106/ https://www.ncbi.nlm.nih.gov/pubmed/33458253 http://dx.doi.org/10.12688/wellcomeopenres.16157.2

Ejemplares similares

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
por: McNaughton, Anna L., et al.
Publicado: (2019)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
por: Campbell, Cori, et al.
Publicado: (2020)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
por: Downs, Louise O., et al.
Publicado: (2023)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
por: Downs, Louise O., et al.
Publicado: (2019)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection
por: Chowdhury, Fazle Rabbi, et al.
Publicado: (2021)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
por: McNaughton, Anna L., et al.
Publicado: (2019)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
por: Campbell, Cori, et al.
Publicado: (2023)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
por: Pley, Caitlin, et al.
Publicado: (2022)

FAIR data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect
por: Matthews, Philippa C
Publicado: (2019)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Polymorphisms predicting phylogeny in hepatitis B virus
por: Lourenço, José, et al.
Publicado: (2022)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
por: Chinnakannan, Senthil K., et al.
Publicado: (2020)

Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts
por: Brown, Robin, et al.
Publicado: (2022)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
por: Lumley, Sheila F., et al.
Publicado: (2018)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
por: Bonsall, David, et al.
Publicado: (2015)

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
por: O'Hara, Geraldine, et al.
Publicado: (2020)

Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
por: Smith, David, et al.
Publicado: (2018)

DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites
por: Wu, Canbiao, et al.
Publicado: (2021)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Epstein-Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype
por: Goh, Cyndi, et al.
Publicado: (2020)

Hepatitis B Virus Prevalence and Mother-to-Child Transmission Risk in an HIV Early Intervention Cohort in KwaZulu-Natal, South Africa
por: Millar, Jane, et al.
Publicado: (2023)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
por: Cargill, Tamsin, et al.
Publicado: (2023)

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda
por: Martyn, Emily, et al.
Publicado: (2023)

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
por: Jooste, Pieter, et al.
Publicado: (2016)

Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway
por: Manso, Carmen F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rr7jq7ir74iagjhh20i89bn78